G - Physics
01
N
G01N 33/50 (2006.01) A61K 45/00 (2006.01) G01N 33/15 (2006.01) G01N 33/566 (2006.01) G01N 33/68 (2006.01) G01N 33/74 (2006.01)
Patent
CA 2392774
A method of screening a compound, which is capable of changing the binding property of neuromedin U or its salt to FM-3 or its salt, or a salt thereof characterized by using neuromedin U, its derivative or its salt and FM-3 or its salt. This method is usable in screening preventives and remedies for hypertension, stress diseases, etc. An FM-3 antagonist is useful as a preventive and a remedy for hypertension, stress diseases and the like.
L'invention concerne un composé de criblage d'un composé -ou d'un sel de celui-ci- permettant de changer la propriété de liaison de la neuromédine U, ou du sel de celle-ci, en FM-3 ou en sel de celui-ci. Ce procédé est caractérisé en ce que l'on utilise la neuromédine U, le dérivé ou sel de celle-ci et FM-3 ou le sel de celui-ci. On peut utiliser ce procédé pour cribler des médicaments de prévention et de traitement de l'hypertension, des maladies du stress, etc... L'invention concerne encore un antagoniste de FM-3, utile en tant que médicament de prévention et de traitement de l'hypertension, des maladies du stress et analogue.
Fukusumi Shoji
Hinuma Shuji
Hosoya Masaki
Kawamata Yuji
Fetherstonhaugh & Co.
Takeda Chemical Industries Ltd.
Takeda Pharmaceutical Company Limited
LandOfFree
Screening method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Screening method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening method will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1925664